Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
CASH FLOW FROM OPERATING ACTIVITIES:
Net loss	$ (299,214)	$ (315,579)
Adjustments to reconcile net loss to cash used for operating activities:
Depreciation	10,258	5,736
Amortization
Intangible assets	3,401	2,818
Deferred costs		1,682
Share-based compensation	85,773	12,447
Loss on derivative liabilities	204,948
Change in assets and liabilities:
Accounts receivable trade	(1,061,936)	155,674
Due from factor	(8,111)	95,524
Inventory	429	(165)
Prepaid expenses and other	(12,951)	(34,215)
Accounts payable	(217,070)	(281,968)
Accrued liabilities	(1,874)	(207,976)
Deferred revenue	19,718	(41,412)
Net cash used for by operating activities	(1,276,629)	(607,434)
CASH FLOW FROM INVESTING ACTIVITIES:
Capital expenditures	(3,799)
Net cash used for investing activities	(3,799)
CASH FLOW FROM FINANCING ACTIVITIES:
Repurchase of outstanding warrants	(150,000)
Issuance of common stock		902,693
Repayment of note payable – related party		(321,428)
Proceeds from issuance of note payable		497,307
Costs to issue common stock		(46,176)
Financing costs for note payable		(57,203)
Net cash (used for) provided by financing activities	(150,000)	975,193
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	(1,430,428)	367,759
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	2,023,349	83,989
CASH AND CASH EQUIVALENTS, END OF PERIOD	592,921	451,748
Cash paid for:
Interest